SCHEMBL26340321

SCHEMBL26340321

c1ccc(-c2ccc(N(c3ccc(-c4ccc5c(c4)c(-c4ccccc4)c(-c4ccccc4)c4ccccc45)cc3)c3ccc4oc5ccccc5c4c3)cc2-c2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 5/20 0.38
▸ PLA2G4A P47712 5/20 0.38
▸ PLA2G10 O15496 1/20 0.34
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ THRB P10828 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ MMP12 P39900 1/20 0.32
▸ MMP13 P45452 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ HSP90AB1 P08238 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26337854 0.94 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL26340315 0.94 MEN1 (0.37) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL26336228 0.94 MEN1 (0.37) PLA2G2APLA2G4AMEN1KMT2AKDM4E
SCHEMBL26340466 0.93 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL26340375 0.93 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL26340363 0.92 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL26336280 0.91 HPGD (0.40) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL26336365 0.91 HPGD (0.40) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL26340334 0.90 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL26337927 0.90 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, ELAVL1, PIEZO1 PLA2G2A 4650/4885PLA2G4A 4773/4885PLA2G10 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback